Correlation Between Morgan Stanley and BriaCell Therapeutics

Can any of the company-specific risk be diversified away by investing in both Morgan Stanley and BriaCell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Morgan Stanley and BriaCell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Morgan Stanley Direct and BriaCell Therapeutics Corp, you can compare the effects of market volatilities on Morgan Stanley and BriaCell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Morgan Stanley with a short position of BriaCell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Morgan Stanley and BriaCell Therapeutics.

Diversification Opportunities for Morgan Stanley and BriaCell Therapeutics

0.74

Correlation Coefficient

Morgan Stanley  BriaCell Therapeutics

Poor diversification

The 3 months correlation between Morgan and BriaCell is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Morgan Stanley Direct and BriaCell Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BriaCell Therapeutics and Morgan Stanley is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Morgan Stanley Direct are associated (or correlated) with BriaCell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BriaCell Therapeutics has no effect on the direction of Morgan Stanley i.e., Morgan Stanley and BriaCell Therapeutics go up and down completely randomly.

Pair Corralation between Morgan Stanley and BriaCell Therapeutics

Given the investment horizon of 90 days Morgan Stanley Direct is expected to generate 0.19 times more return on investment than BriaCell Therapeutics. However, Morgan Stanley Direct is 5.24 times less risky than BriaCell Therapeutics. It trades about 0.04 of its potential returns per unit of risk. BriaCell Therapeutics Corp is currently generating about 0.0 per unit of risk. If you would invest  1,907  in Morgan Stanley Direct on September 13, 2024 and sell it today you would earn a total of  223.00  from holding Morgan Stanley Direct or generate 11.69% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	45.82%
Values	Daily Returns

Morgan Stanley Direct  vs.  BriaCell Therapeutics Corp

Morgan Stanley Direct

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Morgan Stanley Direct are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite quite weak fundamental indicators, Morgan Stanley may actually be approaching a critical reversion point that can send shares even higher in January 2025.

BriaCell Therapeutics

Risk-Adjusted Performance

16 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in BriaCell Therapeutics Corp are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, BriaCell Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Morgan Stanley and BriaCell Therapeutics

The main advantage of trading using opposite Morgan Stanley and BriaCell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Morgan Stanley position performs unexpectedly, BriaCell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BriaCell Therapeutics will offset losses from the drop in BriaCell Therapeutics' long position.

The idea behind Morgan Stanley Direct and BriaCell Therapeutics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.